Abstract
The article presents a description of a clinical case of the course of the new coronavirus infection in a patient with a diffuse form of scleroderma. The debut of the viral infection occurred against the background of a long course of systemic scleroderma, as well as long-term therapy with immunosuppressive drugs. The complexity of diagnosing and managing patients with COVID-19 combined with immunoinflammatory rheumatic diseases is discussed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
